Timothy Warbington is CEO & President +1 at CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ). They have made 11 open-market trades across 1 company since 2016, most recently 2026-09-24.
CIK 0001674492
6 open-market purchases totalling $102K since 2016, against 5 sales. Across 6 scored buys the stock is down 1.5% at ninety days, and 2.5 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| CELZ | 1,034,904 | $776K |
Shares reported on the most recent Form 4, priced at the 2026-09-25 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 17% | 17% | 33% |
| Avg Move | -10.5% | -14.5% | -1.5% |
| Alpha | -27.4% | -15.4% | -2.5% |
| Scored | 6 | 6 | 6 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 100% | 100% |
| Avg Move | -23.4% | -30.9% | -30.9% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CELZ | BUY | 2023-06-27 | 2023-06-29 | $4.42 | $4K | +13.0% | +17.2% | +16.0% |
| CELZ | BUY | 2022-11-21 | 2022-11-23 | $0.39 | $10K | -3.9% | -7.5% | +87.9% |
| CELZ | BUY | 2022-09-27 | 2022-09-28 | $0.50 | $10K | -4.0% | -18.4% | -27.2% |
| CELZ | BUY | 2022-09-21 | 2022-09-22 | $0.59 | $25K | -15.4% | -20.8% | -32.6% |
| CELZ | BUY | 2022-06-06 | 2022-06-07 | $0.91 | $23K | -29.4% | -26.5% | -22.2% |
| CELZ | SELL | 2017-08-29 | 2017-08-31 | $0.20 | $1K | -23.4% | -30.9% | -30.9% |
| CELZ | SELL | 2017-06-05 | 2017-06-07 | $0.30 | $2K | -23.4% | -30.9% | -30.9% |
| CELZ | SELL | 2017-06-02 | 2017-06-05 | $0.41 | $2K | -23.4% | -30.9% | -30.9% |
| CELZ | SELL | 2017-05-18 | 2017-05-19 | $0.45 | $630 | -23.4% | -30.9% | -30.9% |
| CELZ | SELL | 2016-12-18 | 2017-01-06 | $0.07 | $621K | -23.4% | -30.9% | -30.9% |
| CELZ | BUY | 2016-09-30 | 2016-11-14 | $0.10 | $30K | -23.4% | -30.9% | -30.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| Scored | 5 | 5 | 5 |